Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1998
11/25/1998EP0879235A1 Purine and guanine derivatives
11/25/1998EP0879233A1 Chinoline and benzimidazole derivatives as bradykinin agonists
11/25/1998EP0879231A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/25/1998EP0879227A1 Tyrosin-derivate as alpha-v-integrin inhibitors
11/25/1998EP0879053A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
11/25/1998EP0711291B1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists
11/25/1998EP0695189B1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors
11/25/1998EP0663916B1 O-alkylated rapamycin derivative and its use, particularly as immunosuppressant
11/25/1998EP0654994B1 Use of cineol or menthol for the treament of asthma
11/25/1998EP0652866B1 Azacyclic compounds
11/25/1998EP0649303B1 Substituted arginines and substituted homoarginines and use thereof
11/25/1998EP0624159B1 Pyridyl substituted imidazoles
11/25/1998EP0621773B1 Formulation and use of carotenoids in treatment of cancer
11/25/1998EP0620004B1 Medicinal composition
11/25/1998EP0601043B1 Hybrid cytokines
11/25/1998CN1200122A Lubeluzole N-oxide
11/25/1998CN1200120A Piperazino derivatives as neurokinin antagonists
11/25/1998CN1200119A (Methylsulfonyl) phenyl-2-(5H)-furanones as cox-2 inhibitors
11/25/1998CN1200036A Compositions with anti-apoptotic activity, containing a mixture of phospholipids
11/25/1998CN1200035A Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
11/25/1998CN1199638A Slimming tea and its preparation
11/25/1998CN1199613A Preparation having increased in vivo tolerability
11/25/1998CN1040873C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, salts and composition and their application and producing process
11/24/1998US5840979 Useful in the treatment and prevention of diseases in which cell death occurs by apoptosis
11/24/1998US5840974 Metalloproteinase inhibitors
11/24/1998US5840939 Derivatives of succinamide and their use as metalloproteinase inhibitors
11/24/1998US5840911 Imidazole derivatives, their preparation and their use as S-adenosylmethionine decarboxylase (=SAMDC) inhibitors
11/24/1998US5840906 Forming anabaseine using nicotinyl piperidone salt
11/24/1998US5840903 5-ht3 and 5-ht4 agonists and antagonists
11/24/1998US5840900 High molecular weight polymer-based prodrugs
11/24/1998US5840846 Fibronectin binding protein as well as its preparation
11/24/1998US5840845 Senescent cell derived inhibitors of DNA synthesis
11/24/1998US5840837 Coupling protected amino acids, optionally on a resin, deprotecting and purifying polypeptide product
11/24/1998US5840767 Perfluorocarbons for biological gas exchange and method
11/24/1998US5840745 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
11/24/1998US5840739 Thiazoline acid derivatives
11/24/1998US5840726 Tachykinin receptor antagonists; useful in treating asthma, cough and bronchitis
11/24/1998US5840725 Substituted oximes, hydrazones and olefins as neurokinin antagonists
11/24/1998US5840721 Imidazole derivatives as MDR modulators
11/24/1998US5840719 Apoptosis inhibitors for treating neurodegenerative diseases
11/24/1998US5840712 Water soluble vitamin B12 receptor modulating agents and methods related thereto
11/24/1998US5840705 α-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
11/24/1998US5840701 Antiischemic agents and macomolecules
11/24/1998US5840693 Vascular endothelial growth factor-B
11/24/1998US5840687 Polypeptides for kinases
11/24/1998US5840673 Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumors
11/24/1998US5840569 Human GTP-binding proteins
11/24/1998US5840535 DNA encoding a zinc ring protein
11/24/1998US5840531 Expression of mammalian islet cell neogenesis associated protein; vectors, probes, antisense constructs
11/24/1998US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis
11/24/1998US5840495 Methods for diagnosis of conditions associated with elevated levels of telomerase activity
11/24/1998US5840337 Gelling liquid polyethylene glycol at room temperature with calcium acetate
11/24/1998US5840311 Administering hepatocyte growth factors to treat fibrosis disorder; increases collagenase activity
11/24/1998US5840304 Amino acid sequences and codes for t-cells
11/24/1998US5840296 Engineered cytotoxic ribonuclease A
11/24/1998US5840294 Method for treating amyloidosis
11/24/1998US5840277 Treatment of chronic pulmonary inflammation
11/24/1998CA2108584C Substituted azetidinones as anti-inflammatory and antidegenerative agents
11/23/1998CA2232809A1 Novel compounds
11/23/1998CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/19/1998WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998WO1998051796A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998WO1998051793A1 Apo-2 RECEPTOR
11/19/1998WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
11/19/1998WO1998051702A1 Methods and compositions for destruction of selected proteins
11/19/1998WO1998051686A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
11/19/1998WO1998051678A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
11/19/1998WO1998051676A1 Efficient enantioselective addition reaction using an organozinc reagent
11/19/1998WO1998051671A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/19/1998WO1998051669A1 Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp
11/19/1998WO1998051668A1 Piperidine derivatives as neurotransmitter re-uptake inhibitors
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051664A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998WO1998051662A2 Compounds and methods for the inhibition of the expression of vcam-1
11/19/1998WO1998051655A1 Excitatory amino acid receptor modulators
11/19/1998WO1998051346A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998WO1998051344A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998WO1998051337A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998WO1998051324A1 Peptide parathyroid hormone analogs
11/19/1998WO1998051321A1 Tissue factor for influencing blood vessel formation
11/19/1998WO1998051313A1 Remedies for dry eye
11/19/1998WO1998051308A1 METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS
11/19/1998WO1998051307A1 METHODS FOR TREATING INFLAMMATION, INFLAMMATORY DISEASES, ARTHRITIS AND STROKE USING pADPRT INHIBITORS
11/19/1998WO1998051305A1 Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes
11/19/1998WO1998051302A1 Composition and methods for treating alzheimer's disease and other amyloidoses
11/19/1998WO1998051291A1 Use of a pharmaceutical composition for treating and/or preventing ischemia
11/19/1998WO1998051289A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998WO1998051277A1 Medical uses of pyruvates
11/19/1998WO1998051164A1 Feed composition for broilers and method for breeding broilers
11/19/1998WO1998040086A3 Essential oil composition
11/19/1998WO1998035061A3 Member of the tnf family useful for treatment and diagnosis of disease
11/19/1998WO1998034640A3 Synthetic hiv gag genes
11/19/1998WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998WO1998026062A3 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
11/19/1998CA2428130A1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998CA2290477A1 Polynucleotides encoding a cd53-like transmembrane protein
1 ... 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 ... 1564